Prescription Drug Information: Abacavir (Page 7 of 7)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
ABACAVIR abacavir tablet, film coated | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
Labeler — Cipla USA Inc. (078719707) |
Registrant — Cipla USA Inc. (078719707) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Cipla Patalganga | 916940208 | ANALYSIS (69097-514), LABEL (69097-514), MANUFACTURE (69097-514), PACK (69097-514) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Cipla Kurkumbh | 917066446 | API MANUFACTURE (69097-514) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Mylan-Laboratories Limited | 650438158 | API MANUFACTURE (69097-514) |
Revised: 12/2020 Cipla USA Inc.
RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.